Back

Questions from the audience and discussion

2 September 2019 (11:51 - 11:54)
Organised by:
Congress Presentation Part of: Hot Line Session 3 Pharmacotherapy ESC Premium Access ESC Congress 2019

14 More presentations in this session

Presentation thumbnail
Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Discussant review - Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease
Professor J. Hopewell (Oxford, GB)
Slides Video
Presentation thumbnail
Questions from the audience and discussion
Video
Presentation thumbnail
AFIRE - Rivaroxaban monotherapy versus combination therapy in patients with atrial fibrillation and stable coronary artery disease
Doctor S. Yasuda (Sendai, JP)
Slides Video
Presentation thumbnail
Discussant review - AFIRE
Professor F. Verheugt (Amsterdam, NL)
Slides Video

Access the full session

Session thumbnail
Hot Line Session 3

The Event

Event poster

ESC Congress 2019

2 September 2019 11:51 CET
You may be interested in
thumbnail
Congress Presentation
Questions & answers.
4 April 2022
thumbnail
Congress Presentation
Innovation and integration in cardiovascular medicine - discussion
1 September 2025
thumbnail
Congress Presentation
The environment as a major cardiovascular risk factor - discussion
3 April 2025
thumbnail
Congress Session
The floor is yours: bring your questions on strategies for complex percutaneous coronary intervention
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources